NCT05818800

Brief Summary

The goal of this clinical trial is to understand whether the adoption of digital solutions by healthcare professionals and patients improves the management of patients with high blood pressure. The main questions it aims to answer are:

  • are these digital solutions feasible and well accepted by patients?
  • can these solutions, compared to standard care, allow a better hypertension control in patients with high blood pressure? Participants randomised to one of the two intervention arms will be asked to adopt the digital solutions that include a smartphone app and 2 devices for blood pressure and body weight measurement that will be connected to the app. Researchers will compare patients randomised in the two intervention groups with patients randomised to standard care (control group)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 17, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 19, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

1 year

First QC Date

March 20, 2023

Last Update Submit

February 28, 2024

Conditions

Keywords

Digital Technologyhypertensionblood pressure

Outcome Measures

Primary Outcomes (1)

  • Changes in blood pressure

    The changes in systolic and diastolic blood pressure

    2 and 6 months

Secondary Outcomes (1)

  • The user satisfaction measured with VAS

    2 and 6 months

Other Outcomes (1)

  • Quality of life measured with EQ-5D

    2 and 6 months

Study Arms (3)

Solution 1 - HSmartBPM (developed by a supplier consortium led by GNOMON)

OTHER

Solutions consist of devices (e.g., blood pressure monitors, body composition scales) working together in an ecosystem enabled by a user-facing service and associated interfaces. Users are invited to a dedicated training session at the pilot site to officially become enrolled and begin using the solution for an extended period of time. During that time, users are instructed to use the solutions based on recommendations by their treating physicians (e.g., regular measurement of blood pressure using the solution, or scheduling of regular visits via the solution interface). Questionnaires are administered via the solution's interface at the beginning and end of the trial duration. At the end of the trial, the user is asked to return the devices to the pilot site.

Device: digital solution

Solution 2 - HyperHealth (developed by a supplier consortium led by TECH4CARE)

OTHER

Solutions consist of devices (e.g., blood pressure monitors, body composition scales) working together in an ecosystem enabled by a user-facing service and associated interfaces. Users are invited to a dedicated training session at the pilot site to officially become enrolled and begin using the solution for an extended period of time. During that time, users are instructed to use the solutions based on recommendations by their treating physicians (e.g., regular measurement of blood pressure using the solution, or scheduling of regular visits via the solution interface). Questionnaires are administered via the solution's interface at the beginning and end of the trial duration. At the end of the trial, the user is asked to return the devices to the pilot site.

Device: digital solution

control

OTHER

the control group where they will be followed according to standard care

Other: Standard Care

Interventions

randomised controlled trial where patients with hypertension will be randomised either to one of the two digital solutions

Solution 1 - HSmartBPM (developed by a supplier consortium led by GNOMON)Solution 2 - HyperHealth (developed by a supplier consortium led by TECH4CARE)

randomised controlled trial where patients with hypertension will be randomised r to standard care

control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with essential hypertension (\>140/90 mmHg or normal BP with antihypertensive treatment)
  • Basic ICT knowledge and ability to access the internet at home and on mobile devices
  • aged 18+
  • ability to provide written informed consent, giving informed consent.
  • written informed consent

You may not qualify if:

  • inability to consent
  • chronic renal replacement therapy (haemodialysis, peritoneal dialysis or transplantation) or if, at baseline, there is a history of active malignancy within the last five years
  • pregnancy
  • illiterate
  • younger than 18 years
  • being a prisoner
  • being institutionalized
  • the patient is mentally or psychiatrically ill
  • the patient has barriers to understand the implications of participation to the study
  • the patient is critically ill or dying
  • the patient is extremely poor
  • the patient has a learning disability
  • the patient is sedated or unconscious
  • the patient is a refugee with no permanent permission to stay
  • the patient does not have a good command of the language
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Auxologico Italiano IRCCS

Milan, 20149, Italy

Location

MeSH Terms

Conditions

Hypertension

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Gianfranco Parati, MD

    Istituto Auxologico Italiano

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This will be a randomised controlled trial where patients with hypertension will be randomised either to one of the two digital solutions or to standard care.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2023

First Posted

April 19, 2023

Study Start

December 17, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

February 29, 2024

Record last verified: 2024-02

Locations